World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
52
Citations
10882
World Ranking
5294
National Ranking
2365

Best Publications

  • Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues

    Jeff M. Bronstein;Michele Tagliati;Ron L. Alterman;Andres M. Lozano

  • LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

    Laurie J. Ozelius;Geetha Senthil;Rachel Saunders-Pullman;Erin Ohmann

  • Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

    William J Marks;Raymond T Bartus;Joao Siffert;Charles S Davis

  • Botulinum toxin type A in the treatment of upper extremity spasticity : A randomized, double-blind, placebo-controlled trial

    D. M. Simpson;D. N. Alexander;C. F. O'Brien;M. Tagliati

  • Management of Referred Deep Brain Stimulation Failures: A Retrospective Analysis From 2 Movement Disorders Centers

    Michael S. Okun;Michele Tagliati;Michael Pourfar;Hubert H. Fernandez

  • Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.

    Michael S. Okun;Bruno V. Gallo;George Mandybur;Jonathan Jagid

  • Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration

    Ioannis U. Isaias;Ron L. Alterman;Michele Tagliati

  • Deep brain stimulation for primary generalized dystonia: long-term outcomes.

    Ioannis U. Isaias;Ron L. Alterman;Michele Tagliati

  • Impaired sequence learning in carriers of the DYT1 dystonia mutation.

    Maria-Felice Ghilardi;Maren Carbon;Giulia Silvestri;Vijay Dhawan

  • Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

    T. D. Hälbig;W. Tse;P. G. Frisina;B. R. Baker

  • Calculating total electrical energy delivered by deep brain stimulation systems.

    Adam M. Koss;Ron L. Alterman;Michele Tagliati;Jay L. Shils

  • Peripheral Nerve Function in HIV Infection: Clinical, Electrophysiologic, and Laboratory Findings

    Michele Tagliati;Juliet Grinnell;James Godbold;David M. Simpson

  • P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300.

    P. Stanzione;F. Fattapposta;P. Giunti;C. D'Alessio

  • Sixty hertz pallidal deep brain stimulation for primary torsion dystonia

    R. L. Alterman;J. Miravite;D. Weisz;J. L. Shils

  • Treatment of levodopa-induced motor complications.

    Fabrizio Stocchi;Michele Tagliati;C. Warren Olanow

  • Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.

    Jerrold L Vitek;Roshini Jain;Lilly Chen;Alexander I Tröster

  • The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning.

    Michele Tagliati;Michele Tagliati;Ivan Bodis-Wollner;Melvin D. Yahr

  • Safety of MRI in patients with implanted deep brain stimulation devices.

    Michele Tagliati;Joseph Jankovic;Fernando Pagan;Frandy Susatia

  • Cerebellar degeneration associated with human immunodeficiency virus infection

    M. Tagliati;D. Simpson;S. Morgello;D. Clifford

  • Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease

    S. Kedia;E. Moro;M. Tagliati;A. E. Lang

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: